ArticleCell2010
Preview. MicroRNAs: from decay to decoy.
Article in Cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Recent Advances in miRNA-Based Therapy for MASLD/MASH and MASH-Associated HCC.International journal of molecular sciences · 2024Review
- Circulating miRNAs as Novel Clinical Biomarkers in Temporal Lobe Epilepsy.Non-coding RNA · 2024Review
- miRSCAPE - inferring miRNA expression from scRNA-seq data.iScience · 2022Article
- Loss of MEG3 and upregulation of miR-145 play an important role in the invasion and migration of Cr(VI)-transformed cells.Heliyon · 2022Article
- STAT3 regulates miR93-mediated apoptosis through inhibiting DAPK1 in renal cell carcinoma.Cancer gene therapy · 2021Article
- MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways.Oncology letters · 2020Article
- Proliferation of vascular smooth muscle cells under inflammation is regulated by NF-κB p65/microRNA-17/RB pathway activation.International journal of molecular medicine · 2018Article
- Meta-analysis of microRNAs as biomarkers for muscle-invasive bladder cancer.Biomedical reports · 2016Article
- The emerging role of miRNAs in inflammatory bowel disease: a review.Therapeutic advances in gastroenterology · 2015Review
- MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled.World journal of gastroenterology · 2013Review
- MicroRNAs in Head and Neck Cancer.International journal of dentistry · 2013Review
- Article
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.EMBO molecular medicine · 2012Review
- Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21(WAF1/CIP1).Cell death and differentiation · 2011Article
- Regulation of microRNA expression and function by nuclear receptor signaling.Cell & bioscience · 2011Article
- MicroRNAs and Multiple Sclerosis.Autoimmune diseases · 2010Article
- Targeting microRNAs in cancer: rationale, strategies and challenges.Nature reviews. Drug discovery · 2010Review
- The new role of microRNAs in cancer.Future oncology (London, England) · 2010Article
- Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: Focus on hnRNP E1's multifunctional regulatory roles.RNA (New York, N.Y.) · 2010Review
- MicroRNAs: small RNAs with big effects.Transplantation · 2010Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MicroRNAs interact with Argonaute proteins to guide posttranscriptional gene silencing. Eiring et al. (2010) now show that miR-328 has a second function, acting as a decoy by binding to hnRNP E2 and lifting its translational repression of an mRNA involved in myeloid cell differentiation.
Identifiers
20211130What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.